Detectable in tumor samples from TNBC patients. Liu et al., showed that bortezomib inhibited CIP2A
Detectable in tumor samples from TNBC patients. Liu et al., showed that bortezomib inhibited CIP2A in association with pAKT downregulation inside a dose- and time-dependent manner in all sensitive TNBC…